SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pojak watched as the world played hot potato with CTO shit coins. Now, it's his moment. With Pepe's legendary meme power and Wojak's emotional depth, Pojak brings a new level of influence, wealth, and ethics. Born into meme royalty with luxury and wisdom from Pepe and Wojak, he faced hardship when the original developer rugged the project. The community rose up and took control. Pojak was reborn, stronger and more determined.

Pojak

PJ CRYPTO ($PJ) is trending as it gains traction within the Phantom Wallet community. The community highlights its strong chart and growing momentum, viewing it as an opportunity for early movers. Some caution is being advised as well.

Solana Street Bets is not just a memecoin; it's a symbol of creativity, humor, and the power of a united community. Inspired by the infamous /wallstreetbets subreddit. Solana Street Bets is here to put respect on the Wall St originated memes in the industry. Solana Street Bets is a decentralized Solana meme coin inspired by the infamous /wallstreetbets subreddit.

SatoshiStreetBets

SatoshiStreetBets (SSB) is trending as community members discuss new coins launching on Phantom Wallet and those building momentum. Several coins, including $1DOG, $CHINAWINS, and $KABOOM, are generating significant buzz within the SSB community. Discussions also highlight projects focusing on community building and locked liquidity, reflecting a growing interest in projects prioritizing trust and transparency.

Aptera Motors Corp. is an automotive technology company focused on the development, production, and distribution of energy-efficient, solar-powered, battery-electric vehicles. Its flagship product, the Aptera, is a three-wheeled, two-seat solar vehicle designed to reduce reliance on traditional charging by utilizing integrated solar panels. The company was founded by Steve Fambro and Chris Anthony and is headquartered in San Diego, CA.

Aptera Motors Corp - Ordinary Shares - Class B

Aptera Motors Corp

Aptera Motors ($SEV) is trending due to its recent direct listing, which has been marked by extreme volatility and trading halts, sparking community debate about market manipulation. Discussions revolve around the company's long-term viability, production capabilities, and unique solar-powered vehicle design, with some comparing it to other EV companies. The community is actively questioning the stock's potential and speculating on future price movements.

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.

Tempest Therapeutics Inc

TPST is trending amid community speculation about a potential acquisition, fueled by upcoming industry events and chatter around Roche. Discussions revolve around buyout values, potential buyers, and the timing of a deal announcement, with many citing the approaching expiration of management options as a key deadline. The community is weighing the likelihood of a buyout against the backdrop of the company's financial situation and the broader oncology market.

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is trending as the community discusses potential whale accumulation and future utility, while some express concerns about the coin's long-term prospects and compare it to other meme coins. There's also chatter around the broader market trends and potential altcoin season, with some users highlighting potential opportunities in other cryptocurrencies. Community members are also talking about burns and potential developments for SHIB.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

GTBIF is trending as investors discuss potential rescheduling catalysts and Trump's influence on the cannabis sector. Community talking points include the potential for significant gains if rescheduling occurs, with some highlighting GTBIF's strong financials. Some traders believe purchasing the underlying stocks of cannabis ETFs like GTBIF, TCNNF, and CURLF will create a short squeeze.

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Quincy, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis

Trulieve Cannabis is trending as community members discuss the potential impact of federal cannabis rescheduling, particularly with President Trump signaling a decision in the coming weeks. Bullish sentiment is building around the expectation that rescheduling could trigger significant growth and investment in the sector, benefiting US multi-state operators like Trulieve. Community members are actively discussing the potential for Trulieve to reach new highs and capitalize on the momentum.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem ($VSTM) is trending due to positive data from a partner's study in China showing promising results for their lung cancer drug GFH375. Community members are dissecting the data and anticipating potential impacts, with some expressing optimism about a potential buyout and a short squeeze. Broader discussion includes the company's pipeline, comparisons to competitors, and upcoming presentations.

Chagee Holdings Ltd. engages in the sales of freshly-made tea drinks, related raw materials, packaging, teahouse equipment, and other supplies. Its products include tea latte, teapuccino, iced oriental tea, teaspresso, and other creative tea drinks. The company was founded by Jun Jie Zhang in June 2017 and is headquartered in Shanghai, China.

Chagee Holdings Ltd. - ADR

Chagee ($CHA) is trending as the lockup period for pre-IPO investors is set to expire, potentially leading to increased selling pressure, while others point to strong growth numbers and oversold conditions as reasons for optimism. Some traders are comparing $CHA to other Chinese retail stocks and anticipating a possible squeeze, while some are closely watching volume, suggesting it could explode if liquidity returns. The community is also discussing the company's expansion plans and comparing its valuation to competitors.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as investors discuss its potential for acquisition following strategic moves like the Recordati partnership and new data presentations at the European Society of Cardiology (ESC) Congress. The community highlights the company's restructured financials, a strong patent portfolio, and identified synergies, interpreting these factors as signs of increased attractiveness to potential acquirers. Discussions also involve potential combination therapies and ongoing patent litigation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Deutsche Bank AG Buys 7,282 Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX)

Deutsche Bank AG raised its holdings in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX  Free Report) by 16.4% during the third quarter, according to its most recent disclosure with the...

Bristol Myers completes acquisition of Karuna Therapeutics

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Q1 2024 EPS Estimates for Karuna Therapeutics, Inc. (NASDAQ:KRTX) Reduced by Zacks Research

Karuna Therapeutics, Inc. (NASDAQ:KRTX  Free Report)  Zacks Research decreased their Q1 2024 earnings estimates for shares of Karuna Therapeutics in a research report issued to...

Karuna Therapeutics, Inc. (NASDAQ:KRTX) Given Consensus Rating of "Hold" by Analysts

Karuna Therapeutics, Inc. (NASDAQ:KRTX  Get Free Report) has been given an average recommendation of Hold by the sixteen research firms that are currently covering the stock...

Karuna Therapeutics, Inc. (NASDAQ:KRTX) Receives Average Recommendation of "Hold" from Brokerages

Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX  Get Free Report) have received a consensus recommendation of Hold from the sixteen brokerages that are currently covering the...

Karuna Therapeutics, Inc. Expected to Earn FY2026 Earnings of ($4.32) Per Share (NASDAQ:KRTX)

Karuna Therapeutics, Inc. (NASDAQ:KRTX  Free Report)  Stock analysts at Zacks Research issued their FY2026 earnings estimates for shares of Karuna Therapeutics in a research report...

When Will Karuna Therapeutics, Inc. (NASDAQ:KRTX) Turn A Profit?

With the business potentially at an important milestone, we thought we'd take a closer look at Karuna Therapeutics...

Karuna Therapeutics (KRTX, $329.71) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 14, 2024

This is a Bullish indicator signaling KRTX's price could rise from here. Traders may explore going long the stock or buying call options...

Karuna Therapeutics (KRTX, $329.71) RSI Indicator left the overbought zone on March 14, 2024

This is a signal that KRTX's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Karuna Therapeutics gains as HSR waiting period for Bristol-Myers deal expires

Karuna Therapeutics gains as HSR waiting period for Bristol-Myers deal expires...

Karuna Therapeutics is a biopharmaceutical company that develops treatments for psychiatric and neurological conditions. Karuna Therapeutics creates drugs that can significantly improve the lives of people who suffer from neurological and psychiatric illnesses, with a particular focus on schizophrenia and the behavioral symptoms of Alzheimer's disease. The company is skilled in neuroscience and has creative ideas for finding and developing new drugs. Karuna Therapeutics isÂ advancing a pipeline of innovative drugs since its inception with the aim of significantly improving the lives of people suffering from these difficult conditions.

Karuna Therapeutics Inc

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

KRTX
Karuna Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest KRTX News

KRTXKaruna Therapeutics Inc